7729 仲恩生醫本益比河流圖
| 年度/月份 | PER | 近四季每股盈餘 | 本益比(倍) | 月收盤價 |
|---|
| 8倍 | 12倍 | 16倍 | 20倍 | 24倍 | 28倍 |
|---|
| 2026/05 | -12.65 | -6.00 | -48.00 | -72.00 | -96.00 | -120.00 | -144.00 | -168.00 | 75.90 |
| 2026/04 | -13.10 | -6.00 | -48.00 | -72.00 | -96.00 | -120.00 | -144.00 | -168.00 | 78.60 |
| 2026/03 | -13.08 | -6.00 | -48.00 | -72.00 | -96.00 | -120.00 | -144.00 | -168.00 | 78.50 |
| 2026/02 | -14.63 | -6.00 | -48.00 | -72.00 | -96.00 | -120.00 | -144.00 | -168.00 | 87.80 |
| 2026/01 | -12.73 | -6.00 | -48.00 | -72.00 | -96.00 | -120.00 | -144.00 | -168.00 | 76.40 |
| 2025/12 | -9.62 | -6.00 | -48.00 | -72.00 | -96.00 | -120.00 | -144.00 | -168.00 | 57.70 |
| 2025/11 | -7.83 | -6.00 | -48.00 | -72.00 | -96.00 | -120.00 | -144.00 | -168.00 | 46.95 |
| 2025/10 | -7.83 | -6.00 | -48.00 | -72.00 | -96.00 | -120.00 | -144.00 | -168.00 | 46.95 |
| 2025/09 | -8.07 | -6.00 | -48.00 | -72.00 | -96.00 | -120.00 | -144.00 | -168.00 | 48.45 |
| 2025/08 | -8.07 | -6.00 | -48.00 | -72.00 | -96.00 | -120.00 | -144.00 | -168.00 | 48.45 |
| 2025/07 | - | -5.51 | -44.08 | -66.12 | -88.16 | -110.20 | -132.24 | -154.28 | - |
| 2025/06 | - | -5.51 | -44.08 | -66.12 | -88.16 | -110.20 | -132.24 | -154.28 | - |
| 2025/05 | - | -5.51 | -44.08 | -66.12 | -88.16 | -110.20 | -132.24 | -154.28 | - |
| 2025/04 | - | -5.51 | -44.08 | -66.12 | -88.16 | -110.20 | -132.24 | -154.28 | - |
| 2025/03 | - | -5.51 | -44.08 | -66.12 | -88.16 | -110.20 | -132.24 | -154.28 | - |
| 2025/02 | - | -5.51 | -44.08 | -66.12 | -88.16 | -110.20 | -132.24 | -154.28 | - |
| 2025/01 | - | -6.09 | -48.72 | -73.08 | -97.44 | -121.80 | -146.16 | -170.52 | - |
| 2024/12 | - | -6.09 | -48.72 | -73.08 | -97.44 | -121.80 | -146.16 | -170.52 | - |
| 2024/11 | - | -6.09 | -48.72 | -73.08 | -97.44 | -121.80 | -146.16 | -170.52 | - |
| 2024/10 | - | -6.09 | -48.72 | -73.08 | -97.44 | -121.80 | -146.16 | -170.52 | - |
| 2024/09 | - | -6.09 | -48.72 | -73.08 | -97.44 | -121.80 | -146.16 | -170.52 | - |
| 2024/08 | - | -6.09 | -48.72 | -73.08 | -97.44 | -121.80 | -146.16 | -170.52 | - |
| 2024/07 | - | - | - | - | - | - | - | - | - |
| 2024/06 | - | - | - | - | - | - | - | - | - |
| 2024/05 | - | - | - | - | - | - | - | - | - |
| 2024/04 | - | - | - | - | - | - | - | - | - |
| 2024/03 | - | - | - | - | - | - | - | - | - |
| 2024/02 | - | - | - | - | - | - | - | - | - |
| 2024/01 | - | - | - | - | - | - | - | - | - |
| 2023/12 | - | - | - | - | - | - | - | - | - |
| 2023/11 | - | - | - | - | - | - | - | - | - |
| 2023/10 | - | - | - | - | - | - | - | - | - |
| 2023/09 | - | - | - | - | - | - | - | - | - |
| 2023/08 | - | - | - | - | - | - | - | - | - |
| 2023/07 | - | - | - | - | - | - | - | - | - |
| 2023/06 | - | - | - | - | - | - | - | - | - |
| 2023/05 | - | - | - | - | - | - | - | - | - |
| 2023/04 | - | - | - | - | - | - | - | - | - |
| 2023/03 | - | - | - | - | - | - | - | - | - |
| 2023/02 | - | - | - | - | - | - | - | - | - |
| 2023/01 | - | - | - | - | - | - | - | - | - |
| 2022/12 | - | - | - | - | - | - | - | - | - |
| 2022/11 | - | - | - | - | - | - | - | - | - |
| 2022/10 | - | - | - | - | - | - | - | - | - |
| 2022/09 | - | - | - | - | - | - | - | - | - |
| 2022/08 | - | - | - | - | - | - | - | - | - |
| 2022/07 | - | - | - | - | - | - | - | - | - |
| 2022/06 | - | - | - | - | - | - | - | - | - |
| 2022/05 | - | - | - | - | - | - | - | - | - |
| 2022/04 | - | - | - | - | - | - | - | - | - |
| 2022/03 | - | - | - | - | - | - | - | - | - |
| 2022/02 | - | - | - | - | - | - | - | - | - |
| 2022/01 | - | - | - | - | - | - | - | - | - |
| 2021/12 | - | - | - | - | - | - | - | - | - |
| 2021/11 | - | - | - | - | - | - | - | - | - |
| 2021/10 | - | - | - | - | - | - | - | - | - |
| 2021/09 | - | - | - | - | - | - | - | - | - |
| 2021/08 | - | - | - | - | - | - | - | - | - |
| 2021/07 | - | - | - | - | - | - | - | - | - |
| 2021/06 | - | - | - | - | - | - | - | - | - |
| 2021/05 | - | - | - | - | - | - | - | - | - |
| 2021/04 | - | - | - | - | - | - | - | - | - |
| 2021/03 | - | - | - | - | - | - | - | - | - |
| 2021/02 | - | - | - | - | - | - | - | - | - |
| 2021/01 | - | - | - | - | - | - | - | - | - |